Lauren Scarborough, PA
Medical · Tupelo, MSNPI 1952935256
Payments from drug & device makers
What this record shows
Pacira Pharmaceuticals Incorporated accounts for 69.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $854 and has fallen 63.8% since, to $309 in 2025.
Across 32 payments — averaging $43.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$962
- Sanara Medtech Inc.$132
- Endo USA, Inc.$56
- Innovation Technologies Inc$56
- Endo Pharmaceuticals Inc.$47
- Boston Scientific$45
- plus $96 from 4 others
What the payments were for
- Travel & lodging$71751%
- Food & beverage$67849%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 17 | $962 |
| Sanara Medtech Inc. | 1 | $132 |
| Endo USA, Inc. | 3 | $56 |
| Innovation Technologies Inc | 2 | $56 |
| Endo Pharmaceuticals Inc. | 3 | $47 |
| Boston Scientific | 2 | $45 |
| Gentleman Orthopedic Solutions | 1 | $34 |
| Heron Therapeutics, Inc. | 1 | $26 |
| AbbVie | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$697
- CellerateRx$132
How this compares
$1,395 in reported general payments places this provider in the 55th percentile of 65 medical providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 110 | $1,022 |
| Ibuprofen | 51 | $444 |
| Gabapentin | 56 | $398 |
| Methylprednisolone | 60 | $376 |
| Oxycodone Hcl | 56 | $236 |
| Meloxicam | 60 | $123 |
| Tramadol Hcl | 53 | $116 |
Paid to pharmacies, not to this prescriber.
Other medical in Tupelo
- Franklin CrumptonTupelo$3K
- Jacob RowlandTupelo$383
- Shannon YoungerColumbus$63K
- Angela DauroBiloxi$25K
- Jenna HabermanFlowood$14K
- Ashley LarsenOcean Springs$11K
- Elise BuckleyClinton$10K
- Caroline BaldwynMadison$9K
- Miranda SudduthMadison$8K
- Catherine DiazFlowood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.